Merck contract and asmanex hfa

Quote
All those naysayers are proven wrong. We are considered valuable because of our numbers being so good. If we kerp working hard, they might just keep us going on and on. Congrats team..
 


















Anonymous said:
Yes, they will keep meanwhile, the Merck reps will be on a nationwide teleconference tomorrow, finding out their fate.
Click to expand...

HOw do you know they will keep us? There wasn't anything said in the voice mail about contract extension. Only that we are promoting asmanex hfa in the third quarter. Why are y'all assuming the contract is going to be extended?
 












Not a naysayers, just a realist. Have been working contract for a long time. I agree this is a good sign but this does not mean automatic extension. A lot more can come into play. I do work hard and hope its extended. Until they tell us otherwise, I'm planning for this to end at the end of the year.
 






Anonymous said:
Not a naysayers, just a realist. Have been working contract for a long time. I agree this is a good sign but this does not mean automatic extension. A lot more can come into play. I do work hard and hope its extended. Until they tell us otherwise, I'm planning for this to end at the end of the year.
Click to expand...

I say Naysayers Should stop the replenishment of tormenting tails!! Why dear spiritual of Petulance will you knot let Us do what we due Best!? Sell the foreseeable products like shit streaming From diarheartic Monkeys!!!
 












Merck, which is also in the process of selling its $14 billion consumer healthcare unit, is working with an investment bank on the potential sale of the off-patent drugs, which could draw interest from generic drugmakers, the people said.

Merck's off-patent drugs are called "diversified brands" and many are sold in emerging markets.

The sale processes underscore efforts by large drug makers to shed smaller divisions they view as non-core so they can better focus on their mainstay products. They have shown new willingness to consider large asset swaps with rivals to exit weaker businesses and bolster core areas where they are already top players.


So Merck is looking to move Animal Health, Consumer Care and diversified brands. We don't need the money. We are cutting R&D. All three are easy money generators. High growth areas are crowded. I am having a tough time finding the endpoint.[/QUO

What does this mean job or no job tell us!! I think they have no idea if they will keep us
 












Merck announced a major layoffs yesterday that is to take place on June 23rd. It includes VPs all the way down reps. The full time reps inventive will be laid off first.
 




























































Top Bottom
Back
Quote